Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,376.00    -15.00 (-0.63%)
Bid:
2,366.00
Ask:
2,368.00
Spread: 2.00 (0.085%)
Market Cap: £3.97b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

3rd Quarter Results

16 Jan 2025 07:00

RNS Number : 5051T
Whitbread PLC
16 January 2025
 

Positive strategic progress, stable UK performance and continued momentum in Germany

 

Throughout this release percentage growth comparisons are comparing Q3 FY25 performance for the 13 weeks to 28 November 2024 to the same period in FY24, unless stated otherwise.

 

 

Comment from Dominic Paul, Whitbread Chief Executive:

 

"Our Five-Year Plan is set to deliver incremental profit of at least £300m by FY30 and release more than £2bn for shareholders through a combination of dividends and share buy-backs. We are making good progress against our strategic priorities including our Accelerating Growth Plan and cost efficiency programme, and we remain confident in our ability to deliver a step change in profits, margins and returns.

 

"The structural shift in UK supply has meant that Premier Inn is continuing to sustain the significant gains made since the pandemic. Whilst forward visibility remains limited, the favourable supply backdrop, together with our brand strength and commercial initiatives, means we are confident that we can continue to outperform the market.

 

"In Germany, we continued to perform strongly in what is an important trading period. As a result, we remain on track to reach profitability on a run-rate basis this year which is a key milestone and gives us real confidence as we continue to build momentum towards becoming the country's number one hotel brand."

 

Overview

Total UK accommodation sales were in line with last year and we delivered another strong trading performance in Germany. With the expected reduction in UK food and beverage ('F&B') sales as a result of our Accelerating Growth Plan, total Group sales were down 2% to £763m

Premier Inn UK:

Trading improved during the quarter resulting in total accommodation sales broadly in line with last year and up 51% versus FY20; total RevPAR was down 3% and up 35% versus FY20

Premier Inn continued to outperform the midscale and economy ('M&E') sector with total accommodation sales growth 0.8pp ahead and a RevPAR premium of £6.241

F&B sales performed in line with our expectations reflecting the impact of our Accelerating Growth Plan

Premier Inn Germany:

Total accommodation sales were up 23% in local currency (19% in GBP), led by the increasing maturity of our estate and the benefit of our commercial initiatives

Total estate RevPAR increased to €71 and RevPAR of our more established hotels was €79, performing well ahead of the wider M&E market2

Current trading: In the six weeks to 9 January 2025, total UK accommodation sales were up 2% and total Germany accommodation sales were up 37%

£100m share buy-back was completed on 13 November 2024

 

Q3 FY25 Summary

 

 

Q3

Q3 YTD

 

UK

Germany3

Total

UK

Germany3

Total

Sales growth:

Accommodation

0%

19%

1%

0%

21%

2%

Food & beverage

(14)%

22%

(12)%

(9)%

17%

(8)%

Total

(4)%

19%

(2)%

(2)%

20%

(1)%

Like-for-like sales growth:

Accommodation

(3)%

19%

(1)%

(2)%

18%

(1)%

Food & beverage

(1)%

21%

0%

(2)%

14%

(2)%

Total

(3)%

20%

(1)%

(2)%

17%

(1)%

1: STR data, standard basis, 30 August 2024 to 28 November 2024, UK M&E market excludes Premier Inn

2: STR data, standard basis, 30 August 2024 to 28 November 2024, Germany M&E market excludes Premier Inn

3: Germany sales growth in GBP

 

Current trading (six weeks to 9 January 2025) and FY25 guidance

UK total accommodation sales were up 2% with RevPAR in line with last year

UK F&B sales continue to perform in line with our expectations and previous guidance

Germany total accommodation sales were up 37% and RevPAR up 28% in local currency

There is no change to our previous FY25 guidance

  FY26 guidance and outlook

We are making good progress against our strategic priorities and remain on track with our Five-Year Plan. Whilst forward visibility remains limited, we expect to realise further benefits from our commercial initiatives that will enable us to continue to outperform the market

There is no change to our Accelerating Growth Plan guidance and we expect to fully reverse the FY25 PBT negative impact of £20m to £25m

Including the impact of the UK Budget, we expect gross UK cost inflation to be between 5% and 6% on our £1.7bn cost base. However, with efficiencies of £50m, net UK cost inflation is expected to be between 2% and 3%

We're making excellent progress in Germany and with continued estate and brand maturity, we are on track to deliver profitability in FY26

Expected reduction of between £15m and £20m in net finance income versus FY25 reflecting lower cash balances and the impact of refinancing the Group's 2015 bond

 

For more information please contact:

Investor Relations - Whitbread

investorrelations@whitbread.com

Peter Reynolds, Director of Investor Relations

peter.reynolds@whitbread.com

Kirsten O'Reilly, Investor Relations Manager

kirsten.oreilly@whitbread.com

Media - Brunswick

whitbread@brunswickgroup.com

Tim Danaher

+44 (0) 20 7404 5959

 

A live Q&A teleconference for investors and analysts will be held at 9:15am GMT on 16 January 2025. Details to join are noted below. An on-demand version of this will be made available on the website (www.whitbread.com/investors/results-reports-and-presentations) shortly after.

 

Q&A teleconference participant dial-in numbers:

Start time - 9:15am GMT

United Kingdom (Local): 020 3936 2999

Participant Access Code: 005367

 

 

Appendix

 

1) Premier Inn UK key performance indicators

 

 

Q1

Q2

Q3

Q3 %1

YTD

London

 

 

 

Occupancy (full inventory)

78.6%

84.3%

83.1%

(3.2)pp

82.0%

Average room rate (£)

109.12

116.65

112.47

(2.9)%

112.84

Revenue per available room (£)

85.77

98.32

93.49

(6.4%)

92.55

Total accommodation sales (£m)

120.0

138.5

133.9

0.2%

392.4

 

 

 

Regions

 

 

 

Occupancy (full inventory)

82.6%

84.3%

83.9%

(0.8)pp

83.6%

Average room rate (£)

71.00

84.77

74.43

(0.9)%

76.78

Revenue per available room (£)

58.67

71.45

62.43

(1.8)%

64.19

Total accommodation sales (£m)

374.1

456.2

398.7

(0.6)%

1,229.0

 

 

 

Total

 

 

 

Occupancy (full inventory)

81.9%

84.3%

83.7%

(1.2)pp

83.3%

Average room rate (£)

77.59

90.53

81.35

(1.2)%

83.22

Revenue per available room (£)

63.54

76.31

68.12

(2.5)%

69.33

Total accommodation sales (£m)

494.1

594.7

532.7

(0.4)%

1,621.4

 

 

 

Total accommodation sales vs M&E market2

+0.6pp

+0.3pp

+0.8pp

(4.6)pp

+0.6pp

RevPAR premium vs M&E market2

+£5.44

+£6.32

+£6.24

£(0.25)

+£5.99

 

 

 

 

F&B

 

Total food and beverage sales (£m)

191.0

175.1

162.4

(13.6)%

528.5

Total UK sales (£m)

685.2

769.8

695.1

(3.8)%

2,150.0

 

 

2) Premier Inn Germany key performance indicators

 

 

Q1

Q2

Q3

Q3 %1

YTD

Occupancy (full inventory)

64.6%

72.0%

73.5%

7.7pp

70.1%

Average room rate (€)

87.88

90.05

96.89

7.0%

91.81

Revenue per available room (€)

56.79

64.87

71.25

19.6%

64.34

Total accommodation sales (€m)

54.3

62.0

69.3

23.1%

185.7

Total food and beverage (€m)

8.8

9.8

11.3

26.6%

30.0

Total sales (€m)

63.1

71.8

80.7

23.6%

215.6

 

Notes:

1: Growth versus Q3 FY24

2: STR data, standard basis, 1 March 2024 to 28 November 2024, M&E market excludes Premier Inn

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTPKPBQFBKDADD
Date   Source Headline
1st Jul 20269:16 amRNSTotal Voting Rights
18th Jun 20264:45 pmRNSResult of AGM
18th Jun 20267:00 amRNS1st Quarter Results
1st Jun 20269:22 amRNSTotal Voting Rights
29th May 202612:38 pmRNSHolding(s) in Company
22nd May 20265:02 pmRNSDirector/PDMR Shareholding
13th May 20264:46 pmRNSAnnual Financial Report
12th May 20267:34 amRNSDirector Declaration
11th May 20264:40 pmRNSDirector/PDMR Shareholding
8th May 20262:51 pmRNSDirector/PDMR Shareholding
8th May 20262:34 pmRNSHolding(s) in Company
1st May 20269:22 amRNSTotal Voting Rights
30th Apr 20267:02 amRNSOutcome of Business Review
30th Apr 20267:00 amRNSPreliminary Results Announcement
24th Apr 202611:25 amRNSHolding(s) in Company
1st Apr 20269:18 amRNSTotal Voting Rights
2nd Mar 20269:11 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSCORRECTION: Transaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:47 pmRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 202610:34 amRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:37 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.